Project Number GC-2013369 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for FAAH Inhibitors as Alzheimer's Disease Medications (2nd year continuation) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator Makriyannis, Alexandros Principal Investigator First Name Alexandros Principal Investigator Last Name Makriyannis Awardee Organization Northeastern University Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $250,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
